Comparing Platelet-Rich Plasma and Hyaluronic Acid for Knee Osteoarthritis Treatment
Official title: Does Intra-articular Platelet-Rich Plasma Injection Provide Superior Outcomes Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis?
Run by Endeavor Health · NCT03491761 · Data updated 2026-11-12
This study is testing whether platelet-rich plasma or hyaluronic acid works better to relieve pain and improve function in people with knee osteoarthritis.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Endeavor Health Academic / other |
| Locations | 1 site (Skokie, Illinois) |
| Status | Recruiting |
| Started | June 13, 2018 |
| Main results expected | December 2025 |
| Study ends | December 2027 |
| Registry record updated | February 28, 2024 |
| Trial ID | NCT03491761 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 75 with chronic knee pain and a Kellgren-Lawrence grade of 2 or 3.
✕Probably not a fit
Patients with major knee deformities, recent knee surgeries, autoimmune disorders, or those on anticoagulant therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a single-center, prospective, randomized, single-blind study aimed at evaluating the efficacy of platelet-rich plasma (PRP) compared to hyaluronic acid (HA) in treating knee osteoarthritis. The study will involve approximately 100 symptomatic patients diagnosed with knee osteoarthritis, who will be randomly assigned to receive either PRP or HA treatment. The primary endpoint will be measured through MRI-based cartilage thickness, while secondary outcomes will be assessed using the WOMAC total score to evaluate changes in pain and function. The trial will last approximately 13 months, with data collection concluding at month 12 post-treatment.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from knee osteoarthritis, potentially improving their quality of life.
How similar studies have gone: Other studies have shown promising results with PRP in treating knee osteoarthritis, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to provide informed consent * Chronic pain (\>3 months) * Grade 2 -3 according to Kellgren- Lawrence (K-L) classification system (using bilateral anteroposterior radiograph image acquired while the patient is weight-bearing with both knees in full extension) * Minimum score of 40 out of possible 100 on the VAS (Visual Analog Scale) for pain * Age 18 to 75 years old * Physical exam and medical history * Complete Blood Count to include platelets and differential (CBC with Diff) within normal limits * C-Reactive Protein (CRP) within normal limits * Sed Rate (ESR) within normal limits * Survey of current medications Exclusion Criteria: * Presence of major axial deformity (\>5° valgus or varus deviation) * Surgery on target knee within 12 months prior to scheduled treatment * Autoimmune disorder * Active infections * Immuno-suppression (e.g., AIDS, etc.) * Anti-coagulant therapy * Use of NSAIDs 5 days prior to blood draw or up to 7 days after last PRP / HA treatment * Hemoglobin (Hg) \<12 g/dL * Platelet counts (PLT) \<150,000 /mm3 * Previous infiltrative treatment within 3 weeks prior to scheduled treatment * Pregnancy/Breastfeeding * Hypersensitivity to HA * Inability to complete an MRI due to metal implants or claustrophobia * Diabetes * Active treatment for a malignancy * Active wound in the knee * Recent history of knee trauma * Vasovagal history * An injection of hyaluronic acid (HA) or platelet-rich plasma (PRP) to the affected knee within the last two years. * In the judgment of the investigator, the patient is unable to perform and/or complete all of the study visits or treatments required.
Where it's running
-
NorthShore University HealthSystems
Skokie, Illinois, United States Recruiting
Study contacts
- Principal investigator: Jason L Koh, MD, MBA — Clinical Chairman, Dept. of Orthopaedics
- Study coordinator: Jason L Koh, MD, MBA
- Email: jkoh@northshore.org
- Phone: 224-251-3481
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.